Shares of Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) fell 1% during trading on Wednesday . The company traded as low as C$4.05 and last traded at C$4.14. 9,455 shares traded hands during mid-day trading, an increase of 28% from the average session volume of 7,410 shares. The stock had previously closed at C$4.18.
Eupraxia Pharmaceuticals Stock Down 1.0 %
The stock has a 50-day simple moving average of C$3.43 and a 200 day simple moving average of C$3.08.
About Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals Inc, a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis.
Featured Articles
- Five stocks we like better than Eupraxia Pharmaceuticals
- What Investors Need to Know About Upcoming IPOs
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Stock Market Upgrades: What Are They?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
